Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Reduced Immune Response to Inactivated Severe Acute Respiratory Syndrome Coronavirus 2 Vaccine in a Cohort of Immunocompromised Patients in Chile
María Elvira Balcells, Nicole Le Corre, Josefina Durán, et al.
Clinical Infectious Diseases (2022) Vol. 75, Iss. 1, pp. e594-e602
Open Access | Times Cited: 34

Showing 1-25 of 34 citing articles:

Pathophysiological, immunological, and inflammatory features of long COVID
Karen Böhmwald, Benjamín Diethelm‐Varela, Linmar Rodríguez-Guilarte, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 21
People With Human Immunodeficiency Virus Receiving Suppressive Antiretroviral Therapy Show Typical Antibody Durability After Dual Coronavirus Disease 2019 Vaccination and Strong Third Dose Responses
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 7, pp. 838-849
Open Access | Times Cited: 39
The immune response to SARS-CoV-2 in people with HIV
Maxine A. Höft, Wendy A. Burgers, Catherine Riou
Cellular and Molecular Immunology (2023) Vol. 21, Iss. 2, pp. 184-196
Open Access | Times Cited: 38
Growing attention of immunogenicity among patients with autoimmune diseases post-SARS-CoV-2 vaccination: meta-analysis and systematic reviews of the current studies
Chao Zhang, Yuqiang Zhang, Run-Ben Liu, et al.
Annals of Medicine (2025) Vol. 57, Iss. 1
Open Access | Times Cited: 1
Immunogenicity, effectiveness and safety of SARS-CoV-2 vaccination in people living with HIV: A systematic review and meta-analysis
David Griffin, Rekha Pai Mangalore, Jennifer Hoy, et al.
AIDS (2023)
Open Access | Times Cited: 18
Correlation between CD4 T-Cell Counts and Seroconversion among COVID-19 Vaccinated Patients with HIV: A Meta-Analysis
Qian Zhou, Yihuang Liu, Furong Zeng, et al.
Vaccines (2023) Vol. 11, Iss. 4, pp. 789-789
Open Access | Times Cited: 16
Immunogenicity of COVID-19 vaccines and their effect on HIV reservoir in older people with HIV
Vitaliy Matveev, Erik Z. Mihelic, Erika Benko, et al.
iScience (2023) Vol. 26, Iss. 10, pp. 107915-107915
Open Access | Times Cited: 16
Safety and Immunogenicity of Inactivated COVID-19 Vaccines Among People Living with HIV in China
Xiaoxu Han, Xiaobo Yu, Ying Han, et al.
Infection and Drug Resistance (2022) Vol. Volume 15, pp. 2091-2100
Open Access | Times Cited: 22
Immunogenicity and Safety of COVID-19 Vaccines among People Living with HIV: A Systematic Review and Meta-Analysis
Liangyu Kang, Weijing Shang, Peng Gao, et al.
Vaccines (2022) Vol. 10, Iss. 9, pp. 1569-1569
Open Access | Times Cited: 21
SARS-CoV-2 vaccine booster in solid organ transplant recipients previously immunised with inactivated versus mRNA vaccines: A prospective cohort study
M. Dib, Nicole Le Corre, Catalina Ortiz, et al.
The Lancet Regional Health - Americas (2022) Vol. 16, pp. 100371-100371
Open Access | Times Cited: 21
COVID-19 and HSCT (Hematopoietic stem cell transplant)
Lynne Strasfeld
Best Practice & Research Clinical Haematology (2022) Vol. 35, Iss. 3, pp. 101399-101399
Open Access | Times Cited: 20
Efficacy, Immunogenicity, and Safety of COVID-19 Vaccines in Patients with Autoimmune Diseases: A Systematic Review and Meta-Analysis
Alvina Widhani, Anshari Saifuddin Hasibuan, Retia Rismawati, et al.
Vaccines (2023) Vol. 11, Iss. 9, pp. 1456-1456
Open Access | Times Cited: 12
Serological response following COVID-19 vaccines in patients living with HIV: a dose–response meta-analysis
Qian Zhou, Furong Zeng, Yu Meng, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 11
People with HIV receiving suppressive antiretroviral therapy show typical antibody durability after dual COVID-19 vaccination, and strong third dose responses
Hope R. Lapointe, Francis Mwimanzi, Peter K. Cheung, et al.
medRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 18
Immune response of COVID-19 vaccines in solid cancer patients: A meta-analysis
Tiantian Hua, Rui Fan, Fan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 4
Safety and immunogenicity of 3 doses of BNT162b2 and CoronaVac in children and adults with inborn errors of immunity
Daniel Leung, Xiaofeng Mu, Jaime S. Rosa Duque, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 15
Immunogenicity of COVID-19 adsorbed inactivated vaccine (CoronaVac) and additional doses of mRNA BNT162b2 vaccine in immunocompromised adults compared with immunocompetent persons
Karim Yaqub Ibrahim, R. Moreira, C. Santos, et al.
Revista do Instituto de Medicina Tropical de São Paulo (2024)
Open Access | Times Cited: 3
Dynamic immunogenicity after primary and booster inactivated SARS‐CoV‐2 vaccination in people living with HIV: A longitudinal observational study
Ting Lu, Zhiwei Chen, Yu Cao, et al.
Journal of Medical Virology (2023) Vol. 95, Iss. 4
Closed Access | Times Cited: 5
A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients
M. Cecilia Poli, Cecilia Vial, Emma Rey-Jurado, et al.
Vaccines (2023) Vol. 11, Iss. 5, pp. 1012-1012
Open Access | Times Cited: 5
SARS‐CoV‐2 vaccine immunogenicity for people living with HIV: A systematic review and meta‐analysis
Mads Herluf Søndergaard, Jannifer Jasmin Thavarajah, Henry Henson, et al.
HIV Medicine (2023) Vol. 25, Iss. 1, pp. 16-37
Open Access | Times Cited: 5
Advances in Research on COVID-19 Vaccination for People Living with HIV
Junyan Jin, Xiuwen Wang, Raphaël Carapito, et al.
Infectious Diseases & Immunity (2022) Vol. 2, Iss. 4, pp. 213-218
Open Access | Times Cited: 8
Influence of SARS-CoV-2 mRNA Vaccine Booster among Cancer Patients on Active Treatment Previously Immunized with Inactivated versus mRNA Vaccines: A Prospective Cohort Study
Sebastián Mondaca, Benjamín Walbaum, Nicole Le Corre, et al.
Vaccines (2023) Vol. 11, Iss. 7, pp. 1193-1193
Open Access | Times Cited: 4
Seroconversion rate after COVID-19 vaccination in patients with solid cancer: A systematic review and meta-analysis
Juntao Yin, Yangyang Chen, Yang Li, et al.
Human Vaccines & Immunotherapeutics (2022) Vol. 18, Iss. 6
Open Access | Times Cited: 7
Higher antibody responses after mRNA-based vaccine compared to inactivated vaccine against SARS-CoV-2 in Behcet’s syndrome
Ayşe Özdede, Okan Kadir Nohut, Zeynep Atlı, et al.
Rheumatology International (2022) Vol. 42, Iss. 10, pp. 1741-1750
Open Access | Times Cited: 4
Low Performance of Sinovac Vaccine Particularly With Belatacept Therapy in a Study With Different Types of COVID-19 Vaccines in Transplanted Patients
Yazmín Rocío Arias, María Angélica Salinas-Nova, Tatiana Caicedo, et al.
Transplantation Proceedings (2023) Vol. 55, Iss. 3, pp. 500-507
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top